Immuron (IMRN) Total Liabilities (2016 - 2025)
Immuron (IMRN) posted quarterly Total Liabilities of $20607.9 for Q3 2025, down 27.45% year-over-year from $28405.2 in Q3 2024, and down 98.44% quarter-over-quarter from $1.3 million in Q2 2025.
Immuron (IMRN) Total Liabilities (2016 - 2025) Analysis & Trends
Immuron's Total Liabilities history runs 10 years deep, the most recent figure standing at $20607.9 for Q3 2025.
- In Q3 2025, Total Liabilities fell 27.45% year-over-year to $20607.9; the TTM figure through Sep 2025 stood at $20607.9 (down 27.45% YoY), while the FY2025 annual figure was $20607.9, down 27.45% from the prior year.
- Total Liabilities for Q3 2025 stood at $20607.9, down from $1.3 million in the prior quarter.
- The five-year high for Total Liabilities was $1.9 million in Q2 2024, with the low at $8781.5 in Q4 2021.
- The 5-year median for Total Liabilities is $1.1 million (2022), against an average of $800293.9.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities soared 12457.8% in 2022, then sank 98.61% in 2023.
- Immuron's Total Liabilities stood at $8781.5 in 2021, then jumped by 12457.8% to $1.1 million in 2022, then tumbled by 98.61% to $15338.6 in 2023, then soared by 7703.14% to $1.2 million in 2024, then plunged by 98.28% to $20607.9 in 2025.
- Business Quant data shows IMRN's Total Liabilities at $20607.9 in Q3 2025, $1.3 million in Q2 2025, and $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | 20,607.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 20,607.86 |
| Jun 30, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 9, 2024 | 28,405.25 |
| Jun 30, 2024 | 1.87 Mn |
| Dec 31, 2023 | 15,338.64 |
| Sep 28, 2023 | 1.55 Mn |
| Jun 30, 2023 | 23,713.46 |
| Dec 31, 2022 | 1.10 Mn |
| Aug 31, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Dec 31, 2021 | 8,781.48 |
| Jun 30, 2021 | 891,761.59 |
| Jun 30, 2020 | 365,888.56 |
| Dec 31, 2019 | 5.58 Bn |
| Jun 30, 2019 | 847,929.39 |
| Dec 31, 2018 | 521,234.00 |
| Jun 30, 2018 | 608,156.52 |
| Dec 31, 2017 | 914,807.89 |
| Jun 30, 2017 | 1.29 Mn |